fbpx

Year

2017
Lundbeckfonden uddeler hvert år en halv milliard kroner til sundhedsvidenskabelig forskning. Det beløb ser kun ud til at stige de kommende år, og det stiller særlige krav til vores transparens – at vi fortæller åbent og ærligt, hvad vi laver, og hvordan vi gør det. Derfor er vi rigtig glade for, at vi netop –...
Funds further company’s mission to identify and de-risk preclinical rare disease therapeutics, ultimately, spinning out companies with IND-ready programs – Cydan expands leadership team with new chief medical officer and vice president of development Cambridge, Mass., October 17, 2017 – Cydan today announced a new round of financing, raising a committed total of $34 million to advance the company’s...
Der fandtes hverken Tinder eller dating.dk, så det forhistoriske menneske måtte ty til andre hjælpemidler, når det skulle finde en partner uden for den nære familie. Et nyt studie offentliggjort i tidsskriftet Science viser, at forhistoriske mennesker allerede for mindst 34.000 år siden var klar over farerne ved indavl, og derfor bevidst søgte partnere, de...
Lund, Sweden, 12.00 CEST, 13 October 2017 – BONESUPPORT™, an emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique CERAMENT® platform announces the appointment of Helena L Brandt as its new Head of Human Resources. Her appointment is to meet the...
Highly experienced clinical drug developer to oversee R&D functions and Companys Phase 3 development program New Haven, CT, October 12, 2017 – Trevi Therapeutics, Inc. (“Trevi” or the “Company”), a late-stage clinical development company focused on developing Nalbuphine® ER for chronic pruritus (itch), today announced that it has hired Helena Brett-Smith, M.D., as Chief Development Officer. Dr. Brett-Smith has more than...
Planter kan noget ganske særligt. De kan udnytte solens energi til at producere alle de organiske stoffer, de har brug for til deres vækst og udvikling samt til at forsvare sig mod sygdomme og dyr. Alt det klarer planterne baseret på deres evne til at udføre fotosyntese. Typisk producerer planter dog meget små mængder af...
Clinical Data Demonstrate Favorable Safety, Tolerability and Pharmacokinetics Additional Nonclinical Data Show APX001 is Effective Against a Broad Range of Pathogenic Fungi, Including Deadly Candida auris SAN DIEGO – October 9, 2017 – Amplyx Pharmaceuticals, a company developing novel antimicrobial agents for life-threatening fungal infections, today announced that it presented results from two Phase 1 studies of APX001,...
Nogle af de mest spændende videnskabelige opdagelser de seneste mange år er, at søvn og motion gør os lidt klogere og mindsker risikoen for demens. Forskningsmæssigt er disse opdagelser spændende. Det er jo let at forstå, hvorfor muskler og knogler bliver stærkere af motion, men hvorfor fungerer hjernen bedre efter fysisk aktivitet? Hjernen er ikke...
Lund, Sweden, 08:00 CEST 9 October 2017 – BONESUPPORT™ an emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique CERAMENT® platform announces that the first patient has been recruited in a study evaluating CERAMENT® G and CERAMENT® V in...
Favorable Pharmacokinetic and Safety Data for SPR741 Observed at Doses Exceeding the Anticipated Phase 2 Dose Range CAMBRIDGE, Mass., Oct. 03, 2017 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug resistant bacterial infections, today announced data from the Company’s Phase 1 single...
1 3 4 5 6 7 14

Nyheder

Hjernestimulation skal lindre symptomer ved Parkinsons sygdom
25. januar 2021
Minihjerner skal kaste lys over nervesygdomme
25. januar 2021
Mekanismer bag skizofreni
25. januar 2021

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge